Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Dennis Podlesak Insider Profile
4 Followers
Dennis Podlesak, Director at Tobira Therapeutics, holds 0.00 shares in Tobira Therapeutics (Ticker: TBRA), holds 141.76K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 85.25K shares in Adynxx (Ticker: ADYX). Most recently, Dennis Podlesak ― shares of Tobira Therapeutics on ― for an estimated value of ―.
Dennis Podlesak Tobira Therapeutics (TBRA)Director
Tobira Therapeutics (TBRA)
Director
Not Ranked
Dennis Podlesak has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Dennis Podlesak holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 22, 2021 - Apr 22, 2022
Return:+15.70%
The most profitable trade made by Dennis Podlesak
Dennis Podlesak's Trading History
Tobira Therapeutics
―
―
―
$0.00
Syndax Pharmaceuticals
Feb 09, 2024
Director
Uninformative Buy
―
$2.26M
Adynxx
May 07, 2019
Director
Uninformative Buy
―
$1.28K
Avanir Pharmaceuticals
Feb 14, 2014
―
Uninformative Buy
―
―
List of latest transactions for each holding click on a transaction to see Dennis Podlesak's performance on stock
You May Also Like
Dennis Podlesak insider profile FAQ
What is the percentage of profitable transactions made by Dennis Podlesak?
The percentage of profitable transactions made by Dennis Podlesak is ―.
What is the average return per transaction made by Dennis Podlesak?
The average return per transaction made by Dennis Podlesak is ―.
What stocks does Dennis Podlesak hold?
Dennis Podlesak holds: TBRA, SNDX, ADYX, AVNR stocks.
What was Dennis Podlesak’s latest transaction?
Dennis Podlesak latest transaction was an Uninformative Buy of ―.
What was Dennis Podlesak's most profitable transaction?
Dennis Podlesak’s most profitable transaction was an Informative Buy of SNDX stock on April 22, 2021. The return on the trade was 15.70%.
What is Dennis Podlesak's role in Tobira Therapeutics?
Dennis Podlesak's role in Tobira Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.